Nigerian Public Alert 67: NAFDAC Notifies on Unregistered ViroActive+ Drug Purported to Cure HIV

Nigerian Public Alert 67: The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers, patients, and the public about a report concerning the circulation of unregistered ViroActive+ Capsules in Nigeria.

Continue reading Nigerian Public Alert 67: NAFDAC Notifies on Unregistered ViroActive+ Drug Purported to Cure HIV

Nigerian Public Alert 66: NAFDAC Notifies on Mop up of all Otrivin Nasal Drops (0.05% and 0.1%)

Nigerian Public Alert 66: The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers and the public about a report concerning the circulation of counterfeit and unregistered Otrivin Nasal drops (0.05%) for children and (0.01%) for adults in Nigeria.

Continue reading Nigerian Public Alert 66: NAFDAC Notifies on Mop up of all Otrivin Nasal Drops (0.05% and 0.1%)

Nigerian Public Alert 65: NAFDAC Notifies on Counterfeit and Unregistered Cerelac Found on Sale

Nigerian Public Alert 65: The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers, caregivers, and the public about reports of suspected counterfeit and unregistered CERELAC Mixed Fruits and Wheat products being sold in Lagos State, Nigeria.

Continue reading Nigerian Public Alert 65: NAFDAC Notifies on Counterfeit and Unregistered Cerelac Found on Sale

Nigerian Public Alert 64: NAFDAC Notifies on Confirmed Counterfeit of Herceptin 600 mg in Nigeria

Nigerian Public Alert 64: The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare professionals and the public of a confirmed counterfeit batch of Herceptin 600 mg circulating in Nigeria. This alert follows official communications from Roche Nigeria confirming a counterfeit case of Herceptin 600 mg with batch number A8519B34 reported in Lagos state, Nigeria.

Continue reading Nigerian Public Alert 64: NAFDAC Notifies on Confirmed Counterfeit of Herceptin 600 mg in Nigeria

Nigerian Public Alert 63: NAFDAC Notifies on Confirmed Counterfeit of Mabthera 500mg/ 50ml in Nigeria

Nigerian Public Alert 63: The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare professionals and the public of a confirmed counterfeit batch of Mabthera 500mg/50ml circulating in Nigeria. This alert follows official communications from Roche Nigeria confirming counterfeit cases of Mabthera 500mg/50ml with batch number N2110A09 reported in Kaduna and Gombe states of Nigeria.

Continue reading Nigerian Public Alert 63: NAFDAC Notifies on Confirmed Counterfeit of Mabthera 500mg/ 50ml in Nigeria

Nigerian Public Alert 62: NAFDAC Notifies on Confirmed Counterfeit of Avastin 400mg/ 16ml and Tecentriq 1200mg/20ml in Nigeria

Nigerian Public Alert 62: The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare professionals and the public of confirmed counterfeit batches of Avastin® 400mg/16ml (Bevacizumab) and Tecentriq® 1200mg/20ml (Atezolizumab) circulating in Nigeria. This alert is issued in response to official communications from Roche Nigeria, which have confirmed several cases of counterfeit products in Nigeria.

Continue reading Nigerian Public Alert 62: NAFDAC Notifies on Confirmed Counterfeit of Avastin 400mg/ 16ml and Tecentriq 1200mg/20ml in Nigeria

Nigerian Public Alert 61: NAFDAC Notifies on Confirmed Counterfeits PHESGO 600mg With Batch Numbers B2346B16 and C3809C5

Nigerian Public Alert 61: The Marketing Authorization Holder (MAH), Roche, received these complaints from Lagos University Teaching Hospital (LUTH-NSIA) reporting suspected counterfeit Phesgo® 600mg with batch numbers B2346B16 and C3809C5. The batch C3809C5 vial volume was observed to be approximately 20mL instead of the expected 10mL. Both products were reported to be brought in by patients for administration.

Continue reading Nigerian Public Alert 61: NAFDAC Notifies on Confirmed Counterfeits PHESGO 600mg With Batch Numbers B2346B16 and C3809C5